Coating liposomes with collagen (Mr 50,000) increases uptake into liver.

Collagen-coated small unilamellar liposomes were prepared by incubation of two hydrophobic derivatives of collagen (average Mr 50 000) with preformed vesicles. The introduction of hexyl and lauryl residues to the collagen molecule improved by 10-fold the ability of collagen to coat liposomes. In vitro stability of the different coated vesicles prepared, was studied by their ability to retain entrapped carboxyfluorescein as a function of the time. Coated vesicles were clearly more stable in vitro than control liposomes, except for those containing the lauryl derivative in a protein/phospholipid weight ratio higher than 10(-3). Vesicle clearance from circulation as well as tissue distribution were also determined. Pharmacokinetics (determined by both fluorescence and radioactive techniques) were highly dependent on the injected dose, phospholipids used and the content of collagen. Half-lives were maximum for liposomes composed of saturated phospholipids injected at a dose of 2 micromol phospholipid. Besides, blood elimination of collagen-containing vesicles was about 2-fold faster and liver uptake 1.5 to 2-fold higher than control liposomes.

[1]  H. Kleinman,et al.  Role of collagenous matrices in the adhesion and growth of cells , 1981, The Journal of cell biology.

[2]  E. Wisse,et al.  UPTAKE OF LIPOSOMES BY RAT AND MOUSE HEPATOCYTES AND KUPFFER CELLS , 1983 .

[3]  K. Matthay,et al.  Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.

[4]  R. Timpl,et al.  A Two‐Component System of Human Serum Agglutinating Gelatine‐Coated Erythrocytes , 1967, Vital and health statistics. Series 2, Data evaluation and methods research.

[5]  G Blume,et al.  Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.

[6]  K. Hubner,et al.  Gadolinium-labeled liposomes: targeted MR contrast agents for the liver and spleen. , 1987, Radiology.

[7]  V. Torchilin,et al.  Incorporation of hydrophilic protein modified with hydrophobic agent into liposome membrane. , 1980, Biochimica et biophysica acta.

[8]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[9]  E. Pearlstein.  Plasma membrane glycoprotein which mediates adhesion of fibroblasts to collagen , 1976, Nature.

[10]  Dexi Liu,et al.  Size Homogeneity of a Liposome Preparation is Crucial for Liposome Biodistribution in Vivo , 1992 .

[11]  G. Gregoriadis,et al.  Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. , 1982, Life sciences.

[12]  J. Dijkstra,et al.  The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Effects of lanthanum and gadolinium salts. , 1981, Biochimica et biophysica acta.

[13]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[14]  G. Gregoriadis,et al.  Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. , 1979, Biochemical and biophysical research communications.

[15]  M. Padki,et al.  Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect. , 1989, The Journal of pharmacology and experimental therapeutics.

[16]  K. Maruyama,et al.  Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). , 1992, Biochimica et biophysica acta.

[17]  L. Huang,et al.  Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. , 1992, Biochimica et biophysica acta.

[18]  A. Huc,et al.  Stabilization of liposomes with collagen , 1991 .

[19]  T. Allen.  A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles. , 1981, Biochimica et biophysica acta.

[20]  G. Gregoriadis.  Targeting of drugs , 1977, Nature.

[21]  T. Allen,et al.  Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. , 1989, Biochimica et biophysica acta.

[22]  J. Parks,et al.  Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. , 1978, Biochimica et biophysica acta.

[23]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[24]  F. Kaudewitz,et al.  Electrophoretic pattern of and amino acid incorporation in vitro into the insoluble mitochondrial protein of neurospora crassa wild type and mi‐1 mutant , 1968, FEBS letters.

[25]  J. C. Robbins,et al.  Modified in vivo behavior of liposomes containing synthetic glycolipids. , 1981, Biochimica et biophysica acta.

[26]  P. Palatini,et al.  Pharmacokinetic characterization of phosphatidylserine liposomes in the rat , 1991, British journal of pharmacology.

[27]  G Gregoriadis,et al.  Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. , 1991, Biochimica et biophysica acta.

[28]  M. Fonseca,et al.  Synthesis and physicochemical study of collagen hydrophobic derivatives , 1993 .

[29]  G. Scherphof,et al.  Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins. Dependence on cholesterol content and phospholipid composition. , 1981, Biochimica et biophysica acta.

[30]  C. Hunt,et al.  Liposome disposition in vivo. III. Dose and vesicle-size effects. , 1981, Biochimica et biophysica acta.